Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology consensus review on diagnosis, management, and future directions

被引:0
|
作者
Lim-Fat, Mary Jane [1 ]
Bennett, Julie [2 ,3 ]
Ostrom, Quinn [4 ,5 ]
Touat, Mehdi [6 ,7 ]
Franceschi, Enrico [8 ]
Schulte, Jessica [9 ]
Bindra, Ranjit S. [10 ]
Fangusaro, Jason [11 ]
Dhall, Girish [12 ]
Nicholson, James [13 ]
Jackson, Sadhana [14 ]
Davidson, Tom Belle [15 ]
Calaminus, Gabriele [16 ]
Robinson, Giles [17 ]
Whittle, James R. [18 ,19 ,20 ]
Hau, Peter [21 ]
Ramaswamy, Vijay [2 ]
Pajtler, Kristian W. [22 ,23 ,24 ]
Ruda, Roberta [25 ]
Foreman, Nicholas K. [26 ]
Hervey-Jumper, Shawn L. [27 ]
Das, Sunit [28 ]
Dirks, Peter [29 ]
Bi, Wenya Linda [30 ]
Huang, Annie [2 ]
Merchant, Thomas E. [31 ]
Fouladi, Maryam [32 ]
Aldape, Kenneth [33 ]
van den Bent, Martin J. [34 ]
Packer, Roger J. [35 ]
Miller, Julie J. [36 ]
Reardon, David A. [37 ]
Chang, Susan M. [38 ]
Haas-Kogan, Daphne [39 ]
Tabori, Uri [2 ]
Hawkins, Cynthia [40 ]
Monje, Michelle [41 ,42 ]
Wen, Patrick Y. [37 ]
Bouffet, Eric [2 ]
Yeo, Kee Kiat [43 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Neurol, Toronto, ON, Canada
[2] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Sch Med, Durham, NC USA
[5] Cent Brain Tumor Registry United States, Hinsdale, IL USA
[6] Sorbonne Univ, Hop Univ La Pitie Salpetrie Charles Foix, Inst Cerveau, Serv Neurooncol,Inserm,CNRS,UMR S 1127,ICM,AP HP, Paris, France
[7] Brigham & Womens Hosp, Dept Neurol, Boston, MA USA
[8] IRCCS Ist Sci Neurolog Bologna, Nervous Syst Med Oncol Dept, Bologna, Italy
[9] Univ Calif San Diego, Dept Neurosci, La Jolla, CA USA
[10] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA
[11] Emory Univ, Aflac Canc Ctr, Childrens Healthcare Atlanta, Atlanta, GA USA
[12] Childrens Hosp Los Angeles, Dept Hematol Oncol, Los Angeles, CA USA
[13] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England
[14] Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, Bethesda, MD USA
[15] Univ Southern Calif, Childrens Hosp Angeles, Canc & Blood Dis Inst, Keck Sch Med, Los Angeles, CA USA
[16] Univ Hosp Bonn, Paediat Haematol & Oncol, Bonn, Germany
[17] St Jude Childrens Res Hosp, Neurobiol & Brain Tumor Program, Dept Oncol, Memphis, TN USA
[18] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[19] WEHI, Personalised Oncol Div, Parkville, Vic, Australia
[20] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia
[21] Regensburg Univ Hosp, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany
[22] Hopp Childrens Canc Ctr Heidelberg KiTZ, Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[23] German Canc Consortium DKTK, Div Pediat Neurooncol, German Canc Res Ctr DKFZ, Heidelberg, Germany
[24] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[25] Univ Turin & City Hlth, Sci Univ Hosp, Dept Neurosci Levi Montalcini R, Div Neurooncol, Turin, Italy
[26] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA
[27] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[28] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Neurosurg, Toronto, ON, Canada
[29] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada
[30] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA USA
[31] St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN USA
[32] Univ Cincinnati, Med Ctr, Cincinnati Childrens Hosp, Div Hematol Oncol, Cincinnati, OH 45267 USA
[33] NCI, Lab Pathol, Bethesda, MD USA
[34] Erasmus MC Canc Inst, Brain Tumor Ctr, Rotterdam, Netherlands
[35] Childrens Natl Hosp, Ctr Neurosci & Behav Med, Brain Tumor Inst, Gilbert Family Neurofibromatosis Inst, Washington, DC USA
[36] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Neurooncol, Dept Neurol, Boston, MA 02115 USA
[37] Harvard Med Sch, Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
[38] Univ Calif San Francisco, Dept Neurol Surg, Div Neurooncol, San Francisco, CA USA
[39] Harvard Med Sch, Brigham & Womens Hosp, Boston Childrens Hosp, Dana Farber Canc Inst, Boston, MA USA
[40] Hosp Sick Children, Dept Pathol, Toronto, ON, Canada
[41] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[42] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA
[43] Dana Farber Boston Childrens Canc & Blood Disorder, Dept Pediat Oncol, Boston, MA USA
关键词
adolescents and young adults; brain tumors; precision medicine; survivorship; GERM-CELL TUMORS; LOW-GRADE GLIOMA; DABRAFENIB PLUS TRAMETINIB; PEDIATRIC HIGH-GRADE; PHASE-II TRIAL; RADIATION-THERAPY; VINCRISTINE CHEMOTHERAPY; INCIDENCE PATTERNS; SURVIVAL BENEFIT; EPENDYMAL TUMORS;
D O I
10.1093/neuonc/noae186
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adolescents and young adults (AYAs; ages 15-39 years) are a vulnerable population facing challenges in oncological care, including access to specialized care, transition of care, unique tumor biology, and poor representation in clinical trials. Brain tumors are the second most common tumor type in AYA, with malignant brain tumors being the most common cause of cancer-related death. The 2021 WHO Classification for central nervous system (CNS) Tumors highlights the importance of integrated molecular characterization with histologic diagnosis in several tumors relevant to the AYA population. In this position paper from the Society for Neuro-Oncology (SNO), the diagnosis and management of CNS tumors in AYA is reviewed, focusing on the most common tumor types in this population, namely glioma, medulloblastoma, ependymoma, and CNS germ cell tumor. Current challenges and future directions specific to AYA are also highlighted. Finally, possible solutions to address barriers in the care of AYA patients are discussed, emphasizing the need for multidisciplinary and collaborative approaches that span the pediatric and adult paradigms of care, and incorporating advanced molecular testing, targeted therapy, and AYA-centered care.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
    Wen, Patrick Y.
    Weller, Michael
    Lee, Eudocia Quant
    Alexander, Brian M.
    Barnholtz-Sloan, Jill S.
    Barthel, Floris P.
    Batchelor, Tracy T.
    Bindra, Ranjit S.
    Chang, Susan M.
    Chiocca, E. Antonio
    Cloughesy, Timothy F.
    DeGroot, John F.
    Galanis, Evanthia
    Gilbert, Mark R.
    Hegi, Monika E.
    Horbinski, Craig
    Huang, Raymond Y.
    Lassman, Andrew B.
    Le Rhun, Emilie
    Lim, Michael
    Mehta, Minesh P.
    Mellinghoff, Ingo K.
    Minniti, Giuseppe
    Nathanson, David
    Platten, Michael
    Preusser, Matthias
    Roth, Patrick
    Sanson, Marc
    Schiff, David
    Short, Susan C.
    Taphoorn, Martin J. B.
    Tonn, Joerg-Christian
    Tsang, Jonathan
    Verhaak, Roel G. W.
    von Deimling, Andreas
    Wick, Wolfgang
    Zadeh, Gelareh
    Reardon, David A.
    Aldape, Kenneth D.
    van den Bent, Martin J.
    NEURO-ONCOLOGY, 2020, 22 (08) : 1073 - 1113
  • [2] Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
    Vargas Lopez, Antonio Jose
    NEURO-ONCOLOGY, 2021, 23 (03) : 502 - 503
  • [3] Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions
    Aizer, Ayal A.
    Lamba, Nayan
    Ahluwalia, Manmeet S.
    Aldape, Kenneth
    Boire, Adrienne
    Brastianos, Priscilla K.
    Brown, Paul D.
    Camidge, D. Ross
    Chiang, Veronica L.
    Davies, Michael A.
    Hu, Leland S.
    Huang, Raymond Y.
    Kaufmann, Timothy
    Kumthekar, Priya
    Lam, Keng
    Lee, Eudocia Q.
    Lin, Nancy U.
    Mehta, Minesh
    Parsons, Michael
    Reardon, David A.
    Sheehan, Jason
    Soffietti, Riccardo
    Tawbi, Hussein
    Weller, Michael
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2022, 24 (10) : 1613 - 1646
  • [4] Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions
    Wilcox, Jessica A.
    Chukwueke, Ugonma N.
    Ahn, Myung-Ju
    Aizer, Ayal A.
    Bale, Tejus A.
    Brandsma, Dieta
    Brastianos, Priscilla K.
    Chang, Susan
    Daras, Mariza
    Forsyth, Peter
    Garzia, Livia
    Glantz, Michael
    Oliva, Isabella C. Glitza
    Kumthekar, Priya
    Le Rhun, Emilie
    Nagpal, Seema
    O'Brien, Barbara
    Pentsova, Elena
    Lee, Eudocia Quant
    Remsik, Jan
    Ruda, Roberta
    Smalley, Inna
    Taylor, Michael D.
    Weller, Michael
    Wefel, Jeffrey
    Yang, Jonathan T.
    Young, Robert J.
    Wen, Patrick Y.
    Boire, Adrienne A.
    NEURO-ONCOLOGY, 2024, 26 (10) : 1781 - 1804
  • [5] Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
    Miller, Julie J.
    Castro, L. Nicolas Gonzalez
    McBrayer, Samuel
    Weller, Michael
    Cloughesy, Timothy
    Portnow, Jana
    Andronesi, Ovidiu
    Barnholtz-Sloan, Jill S.
    Baumert, Brigitta G.
    Berger, Mitchell S.
    Bi, Wenya Linda
    Bindra, Ranjit
    Cahill, Daniel P.
    Chang, Susan M.
    Costello, Joseph F.
    Horbinski, Craig
    Huang, Raymond Y.
    Jenkins, Robert B.
    Ligon, Keith L.
    Mellinghoff, Ingo K.
    Nabors, L. Burt
    Platten, Michael
    Reardon, David A.
    Shi, Diana D.
    Schiff, David
    Wick, Wolfgang
    Yan, Hai
    von Deimling, Andreas
    van den Bent, Martin
    Kaelin, William G.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2023, 25 (01) : 4 - 25
  • [6] The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors
    Nakamura, Hideo
    Takami, Hirokazu
    Yanagisawa, Takaaki
    Kumabe, Toshihiro
    Fujimaki, Takamitsu
    Arakawa, Yoshiki
    Karasawa, Katsuyuki
    Terashima, Keita
    Yokoo, Hideaki
    Fukuoka, Kohei
    Sonoda, Yukihiko
    Sakurada, Kaori
    Mineharu, Yohei
    Soejima, Toshinori
    Fujii, Motoaki
    Shinojima, Naoki
    Hara, Junichi
    Yamasaki, Kai
    Fujimura, Junya
    Yamasaki, Fumiyuki
    Takahashi, Mayu
    Suzuki, Tomonari
    Sato, Iori
    Nishikawa, Ryo
    Sugiyama, Kazuhiko
    NEURO-ONCOLOGY, 2022, 24 (04) : 503 - 515
  • [7] DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
    Rahman, Rifaquat
    Shi, Diana D.
    Reitman, Zachary J.
    Hamerlik, Petra
    de Groot, John F.
    Haas-Kogan, Daphne A.
    D'Andrea, Alan D.
    Sulman, Erik P.
    Tanner, Kirk
    Agar, Nathalie Y. R.
    Sarkaria, Jann N.
    Tinkle, Christopher L.
    Bindra, Ranjit S.
    Mehta, Minesh P.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2024, 26 (08) : 1367 - 1387
  • [8] Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology
    Zapotocky, Michal
    Ramaswamy, Vijay
    Lassaletta, Alvaro
    Bouffet, Eric
    PEDIATRIC BLOOD & CANCER, 2018, 65 (02)
  • [9] Editorial commentary: Society for Neuro-Oncology 2021 Annual Meeting updates on primary central nervous system tumors
    Singer, Lauren
    Kumthekar, Priya
    CHINESE CLINICAL ONCOLOGY, 2022, 11 (03)
  • [10] Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus
    Schiff, David
    Van den Bent, Martin
    Vogelbaum, Michael A.
    Wick, Wolfgang
    Miller, C. Ryan
    Taphoorn, Martin
    Pope, Whitney
    Brown, Paul D.
    Platten, Michael
    Jalali, Rakesh
    Armstrong, Terri
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2019, 21 (07) : 837 - 853